Results 111 to 120 of about 136,777 (328)

The Inflation Reduction Act and Etanercept

open access: yes
Arthritis &Rheumatology, EarlyView.
Charles L. Bennett   +6 more
wiley   +1 more source

Current Landscape of Short‐T2 Imaging Techniques in the Musculoskeletal System: The Past, Present and Future

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Conventional MRI is limited in imaging tissues with short T2 relaxation times, such as bone, ligaments, and cartilage, due to their rapid signal decay. This limitation has spurred the development of specialized MRI techniques designed specifically for short‐T2 tissue imaging.
Pranjal Rai   +3 more
wiley   +1 more source

Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points. Methods These guidelines are an
Eytan Wine   +24 more
wiley   +1 more source

Association of ankylosing spondylitis with cardiovascular disease: a bidirectional two-sample mendelian randomization study

open access: yesFrontiers in Genetics
BackgroundsCurrent observational investigations hint at a potential linkage between ankylosing spondylitis and cardiovascular wellness. However, the nature of this causality remains to be elucidated.
Pengyu Liu   +8 more
doaj   +1 more source

High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis

open access: yesNeural Regeneration Research, 2015
Thalidomide is an effective drug for the treatment of ankylosing spondylitis but might induce peripheral neuropathy. This major adverse reaction has attracted much concern.
Hong-xia Xue   +5 more
doaj   +1 more source

Seronegative spondyloarthropathies : a review : part I: classification and differential diagnosis [PDF]

open access: yes, 1993
The seronegative spondyloarthropathies comprise a group of non-rheumatoid disorders with similar clinical, laboratory and genetic features. Recognition of new clinical features has supported the notion that they all form part of a clinical spectrum ...
Borg, Andrew A.   +2 more
core  

Physiotherapy In Ankylosing Spondylitis

open access: yesJournal of Education, Health and Sport, 2018
Balcerska Kamila, Bielejewska Marta, Gąsior Paulina, Wrzesiński Bartłomiej. Physiotherapy in ankylosing spondylitis. Journal of Education, Health and Sport. 2018;8(9):1576-1583 eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1438093 http://ojs.ukw.edu.pl/index.php/johs/article/view/6094 https://pbn.nauka.gov.pl/sedno-webapp/works/879772
Paulina Gąsior   +3 more
openaire   +4 more sources

Geographic Variation in Diagnostic Ability and Quality of Care Metrics: A Case Study of Ankylosing Spondylitis and Low Back Pain

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2017
Studies examining geographic variation in care for low back pain often focus on process and outcome measures conditional on patient diagnosis but generally do not take into account a physician’s ability to diagnose the root cause of low back pain. In our
Jason Shafrin PhD   +5 more
doaj   +1 more source

Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

open access: yesAnnals of the Rheumatic Diseases, 2016
Objectives To compare efficacy and safety of various doses of tofacitinib, an oral Janus kinase inhibitor, with placebo in patients with active ankylosing spondylitis (AS, radiographic axial spondyloarthritis). Methods In this 16-week (12-week treatment,
D. M. van der Heijde   +8 more
semanticscholar   +1 more source

Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Osteoporosis, characterized by osteoclastic bone resorption, has been the focus of research. Studies implicate that reactive oxygen species (ROS) accumulate intracellularly during osteoclastogenesis. Salvianolic acid A (SAA), a compound derived from Salvia miltiorrhiza, has been widely used to treat cardiovascular and cerebrovascular disorders,
Hao Qiu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy